Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndromeEffie K Grand, Francis H Grand, Andrew J Chase, et al.
Leukemia Research|September 27, 2005
A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapyLing Yan Zhang, Matthew L Smith, Beate Schultheis, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
British Journal of Haematology|March 12, 2011
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemiaThomas Ernst, Joannah Score, Michael Deininger, et al.
The Lancet. Oncology|July 7, 2007
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemiaAlwin Krämer, Andreas Reiter, Jens Kruth, et al.
British Journal of Haematology|August 21, 2018
Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UKNicholas C P Cross, Helen E White, Paul A S Evans, et al.
Acta Haematologica|May 31, 2018
Absence of CALR Mutations in Idiopathic Erythrocytosis Patients with Low Serum Erythropoietin LevelsMark A Catherwood, Amy Graham, Robert J G Cuthbert, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndromeEffie K Grand, Francis H Grand, Andrew J Chase, et al.
Leukemia Research|September 27, 2005
A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapyLing Yan Zhang, Matthew L Smith, Beate Schultheis, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
British Journal of Haematology|March 12, 2011
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemiaThomas Ernst, Joannah Score, Michael Deininger, et al.
The Lancet. Oncology|July 7, 2007
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemiaAlwin Krämer, Andreas Reiter, Jens Kruth, et al.
British Journal of Haematology|August 21, 2018
Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UKNicholas C P Cross, Helen E White, Paul A S Evans, et al.
Acta Haematologica|May 31, 2018
Absence of CALR Mutations in Idiopathic Erythrocytosis Patients with Low Serum Erythropoietin LevelsMark A Catherwood, Amy Graham, Robert J G Cuthbert, et al.
Pageof 23